Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.39 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.39 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | PTPRC | P08575 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25320059 | 0.85 | PTGDR2 (0.45) | PTGDR2ALDH1A1MAPK1BACE1ESR2 | |
| SCHEMBL28450257 | 0.80 | PTGDR2 (0.42) | PTGDR2ALDH1A1MAPK1BACE1ESR2 | |
| SCHEMBL12551788 | 0.80 | MGLL (0.50) | ALDH1A1BACE1ESR2ALOX5MGLL | |
| SCHEMBL30421069 | 0.78 | ESR2 (0.46) | PTGDR2ALDH1A1MAPK1BACE1ESR2 | |
| SCHEMBL8067754 | 0.78 | CA2 (0.54) | ALDH1A1BACE1ESR2ALOX5MGLL | |
| SCHEMBL25217035 | 0.78 | ESR2 (0.46) | PTGDR2ALDH1A1MAPK1BACE1ESR2 | |
| SCHEMBL8420427 | 0.77 | ALDH1A1 (0.43) | ALDH1A1MAPK1BACE1ESR2ALOX5 | |
| SCHEMBL3110322 | 0.77 | KMT2A (0.44) | PTGDR2ALDH1A1MAPK1BACE1ESR2 | |
| SCHEMBL28972658 | 0.77 | ESR2 (0.40) | BACE1ESR2ALOX5AKR1C3AKR1C2 | |
| SCHEMBL8775538 | 0.76 | SLC6A3 (0.46) | ALDH1A1MAPK1MGLLLMNACA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10134997-B2 | Indenopyridine-based compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-11-20 | — | — | US | disclosed |
| US-20150060808-A1 | INDENOPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2015-03-05 | — | — | US | disclosed |
| US-20110054229-A1 | LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2011-03-03 | — | — | US | disclosed |
| EP-2215185-A1 | LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME | Gracel Display Inc. (KR) | 2010-08-11 | — | — | EP | disclosed |
| WO-2009066815-A1 | LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2009-05-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054229-A1 | LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME | OCIAD2, OCIAD1, ORMDL3 | PTGDR2 3123/4885ALDH1A1 574/4885MAPK1 3026/4885 |
| US-10134997-B2 | Indenopyridine-based compound and organic light-emitting device including the same | QDPR, CACNA1D, TPMT | PTGDR2 213/4885ALDH1A1 127/4885MAPK1 2456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.